| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/10/2011 | WO2011027908A1 Method of selecting safe pluripotent stem cells |
| 03/10/2011 | WO2011027901A1 Selection method of induced pluripotent stem cells |
| 03/10/2011 | WO2011027832A1 Nucleated red blood cell concentrating/collecting chip and nucleated red blood cell concentrating/collecting method |
| 03/10/2011 | WO2011027575A1 Enhancer for promoter, and use thereof |
| 03/10/2011 | WO2011027554A1 Method for transporting potassium ion from front side to back side of lipid bilayer membrane |
| 03/10/2011 | WO2011027552A1 Method for transporting potassium ion from front side to back side of lipid bilayer membrane |
| 03/10/2011 | WO2011027180A1 Cells and methods for obtaining them |
| 03/10/2011 | WO2011027151A1 Stable manufacture of factor viii |
| 03/10/2011 | WO2011026242A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor |
| 03/10/2011 | WO2011026222A1 Transformed human pluripotent stem cells and associated methods |
| 03/10/2011 | WO2011026221A1 Methods of culturing embryoid bodies |
| 03/10/2011 | WO2011000860A3 Human polypeptides that interact with hiv and htlv proteins |
| 03/10/2011 | WO2010123798A3 Compositions for transfection of biomolecules into cells |
| 03/10/2011 | WO2010120749A3 Harnessing cell dynamics to engineer materials |
| 03/10/2011 | WO2010120518A3 Sperm cell separation methods and compositions containing sperm cell targeting ligands for use therein |
| 03/10/2011 | WO2010110596A3 Method for differentiation of stem cells into vascular cells and the induction of angiogenesis using the same |
| 03/10/2011 | US20110061136 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 03/10/2011 | US20110061135 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 03/10/2011 | US20110061134 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
| 03/10/2011 | US20110061133 Plants having increased yield-related traits and a method for making the same |
| 03/10/2011 | US20110061132 Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake |
| 03/10/2011 | US20110061128 IN PLANTA RNAi CONTROL OF FUNGI |
| 03/10/2011 | US20110061127 S-adenosyl-l-methionine synthetase promoter and its use in expression of transgenic genes in plants |
| 03/10/2011 | US20110061126 Plants having increased yield-related traits and a method for making the same |
| 03/10/2011 | US20110061124 Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants |
| 03/10/2011 | US20110061123 Lettuce named gun slinger |
| 03/10/2011 | US20110061122 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics in response to cold |
| 03/10/2011 | US20110061120 Self-cleaving ribozymes and uses thereof |
| 03/10/2011 | US20110061118 Vectors and methods for generating vector-free induced pluripotent stem (ips) cells using site-specific recombination |
| 03/10/2011 | US20110061117 Matrix attachment regions (mars) for increasing transcription and uses thereof |
| 03/10/2011 | US20110061116 Animal Model of Synovial Sarcoma |
| 03/10/2011 | US20110061115 Lung rpogenitor cells, assays, and uses thereof |
| 03/10/2011 | US20110061114 Novel pro258 gene disruptions, and methods relating thereto |
| 03/10/2011 | US20110060130 Neutralizing human anti-igfr antibody |
| 03/10/2011 | US20110060056 Inhibition of the Survival of Gastric Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 03/10/2011 | US20110060049 Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same |
| 03/10/2011 | US20110060047 Approaches to treat cancer using hb-egf inhibitors |
| 03/10/2011 | US20110060032 Lipid encapsulating interfering rna |
| 03/10/2011 | US20110060031 Compositions And Methods For Inhibiting Expression Of A Gene From The Ebola Virus |
| 03/10/2011 | US20110060030 Modulation of apolipoprotein c-iii expression |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110060021 Histone deacetylase inhibitors and uses thereof |
| 03/10/2011 | US20110060014 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 03/10/2011 | US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059953 Compounds for use in stabilizing p53 mutants |
| 03/10/2011 | US20110059901 Compositions and Methods for Treatment of Neoplastic Disease |
| 03/10/2011 | US20110059900 Diagnosing and treating hormone resistant cancers |
| 03/10/2011 | US20110059899 Kruppel-like factor 6 (KLF6), a tumor suppressor protein, and diagnostics, therapeutics, and screening based on this protein |
| 03/10/2011 | US20110059890 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 03/10/2011 | US20110059529 Methods for genetic plant transformation using water-soluble fullerene derivatives |
| 03/10/2011 | US20110059528 Method for Preparing Raw Pollen |
| 03/10/2011 | US20110059527 Active Cell Culture Via Shape Memory |
| 03/10/2011 | US20110059526 Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator |
| 03/10/2011 | US20110059525 Novel Ecdysone Receptor-Based Inducible Gene Expression System |
| 03/10/2011 | US20110059524 Human cdr-grafted antibody and antibody fragment thereof |
| 03/10/2011 | US20110059523 Heat Transfer Baffle System and Uses Thereof |
| 03/10/2011 | US20110059522 Nucleic acids encoding a house dust mite allergen, der p iii, and uses thereof |
| 03/10/2011 | US20110059516 Production of isoprenoids |
| 03/10/2011 | US20110059515 Production of isoprenoids |
| 03/10/2011 | US20110059502 Multiple domain proteins |
| 03/10/2011 | US20110059492 Polypeptides having alpha-amylase activity and polynucleotides encoding same |
| 03/10/2011 | US20110059488 Anti-MPL Antibodies |
| 03/10/2011 | US20110059486 Non-splicing variants of gp350/220 |
| 03/10/2011 | US20110059480 Use of an in vitro hemodynamic endothelial/smooth muscle cell co-culture model to identify new therapeutic targets for vascular disease |
| 03/10/2011 | US20110059479 Modulation of the integrin linked kinase signaling pathway to promote cardiac cell proliferation and self-renewal |
| 03/10/2011 | US20110059456 System for the Cell-Specific and Development-Specific Selection of Differentiating Embryonic Stem Cells, Adult Stem Cells and Embryonic Germline Cells |
| 03/10/2011 | US20110059443 Fluorescent gfp variant displaying highly increased fluorescence intensity without a spectral shift |
| 03/10/2011 | US20110059439 Composition and method for imaging stem cells |
| 03/10/2011 | US20110059187 Peptide dicer substrate agents and methods for their specific inhibition of gene expression |
| 03/10/2011 | US20110059173 encoding a polypeptide comprising a carboxy-terminal amino acid sequence of an alpha Connexin; reduces scar formation |
| 03/10/2011 | US20110059160 Methods and compositions for targeted gene modification |
| 03/10/2011 | US20110059152 Augmentation of organ function |
| 03/10/2011 | US20110059137 Chemokine gene-modified cells for cancer immunotherapy |
| 03/10/2011 | US20110059133 Ex vivo method for producing a preparation containing cd4+ t cells specific for ebv structural antigens |
| 03/10/2011 | US20110059131 Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| 03/10/2011 | US20110059108 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 03/10/2011 | US20110059107 Antikine antibodies that bind to multiple cc chemokines |
| 03/10/2011 | US20110059104 Apo-2L receptor agonist and CPT-11 synergism |
| 03/10/2011 | US20110059101 Amino Acid Sequences Directed Against Il-6 And Polypetides Comprising The Same For The Treatment Of Diseases And Disorders Associated With Il-6 Mediated Signalling |
| 03/10/2011 | US20110059096 Targeting of Notch3 Receptor Function for Cancer Therapy |
| 03/10/2011 | US20110059094 Antitumor effects of insulin-responsive dna binding protein-1 (irdbp-1) |
| 03/10/2011 | US20110059092 Antibodies specific of the beta-amyloid peptides and their uses as diagnostic agents or drugs |
| 03/10/2011 | US20110059091 Inhibitors of oncogenic isoforms and uses thereof |
| 03/10/2011 | US20110059090 Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 03/10/2011 | US20110059087 Il-17 and il-23 antagonists and methods of using the same |
| 03/10/2011 | US20110059081 Methods and compositions for the treatment of receptor tyrosine kinase mediated diseases or disorders |
| 03/10/2011 | US20110059078 Anti-ifnar1 antibodies with reduced fc ligand affinity |
| 03/10/2011 | US20110059075 Aglycosylated immunoglobulin mutants |
| 03/10/2011 | US20110059073 Method for treating infectious disease using monoclonal antibodies |
| 03/10/2011 | US20110059072 Method for treating cancer using monoclonal antibodies |
| 03/10/2011 | US20110059069 Gapr-1 Methods |
| 03/10/2011 | US20110059066 PAKs as Modifiers of the CHK Pathway and Methods of Use |
| 03/10/2011 | US20110059064 Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) w/High Selectivity and Decrease the in vivo DTH-responses in Rats |
| 03/10/2011 | US20110059063 Antigen binding proteins that bind PAR-2 |
| 03/10/2011 | US20110059059 Methods for Treating Ischemic Tissue |
| 03/10/2011 | US20110059057 Keratinocytes expressing exogenous angiogenic growth factors |
| 03/10/2011 | US20110059056 Method for the Generation of Genetically Modified Vertebrate Precursor Lymphocytes and Use Thereof for the Production of Heterologous Binding Proteins |
| 03/10/2011 | US20110059055 Treating myelin diseases with optimized cell preparations |
| 03/10/2011 | US20110059054 Enhanced dendritic cells for cancer immunotherapy |